Successful Co-management between Primary Care and Endocrinology (SCOPE)
CME Credits:
5
MOC Credits:
5

Online

Scope Banner

SCOPE is an educational initiative designed to provide the primary care team with the necessary knowledge and skills to care for common endocrine disorders. This on-demand enduring activity prepares primary care medical professionals for the co-management of diabetes, obesity, thyroid disorders, dyslipidemia, and osteoporosis.

Click the headings below for more information about each topic

Updates in Diabetes Care for Primary Care

Learning Objectives

Upon completion of the activity, participants should be able to:

  • Identify key aspects of the workup for Diabetes
  • Explain aspects of patient presentation and/or course that necessitate referral to an endocrinologist
  • Summarize key characteristics of evidence-based assessment and treatment options for Diabetes
  • Formulate a management plan that includes steps/strategies supporting optimal PCP-endocrinologist collaboration

Faculty

Deborah Hinnen, APN, BC-ADM, CDE, FAAN, FAADE
Memorial Hospital Diabetes Center
University of Colorado Health
Colorado Springs, CO

Accreditation

This activity is provided by American College of Endocrinology in collaboration with The France Foundation.

Target Audience

This educational initiative is intended for primary care physicians, advanced practice professionals (nurse practitioners and physician assistants), nurses, and diabetes educators who care for patients with diseases and disorders of the endocrine system

Statement of Need

In the United States, endocrine-related conditions are on the rise due to the aging population and growing prevalence of type 2 diabetes (T2DM).[i] With three- to six-month wait times for an appointment and an estimated 43,457 patients for every endocrinologist,[ii] the endocrinologist workforce is not sufficient to meet the current demands of patient care. There is also a projected shortfall of endocrine providers, for whom demand will continue to exceed supply through 2025.

Accreditation Statement

The American College of Endocrinology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Physicians

The American College of Endocrinology designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and AACE. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC Medical Knowledge point(s) in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC point(s) equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Disclosures/Conflicts of Interest

Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, The American Association of Clinical Endocrinology (AACE) and The France Foundation (TFF) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. AACE and TFF resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, AACE and TFF seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. AACE and TFF are committed to providing learners with high-quality CME.

Activity Staff Disclosures

The planners, reviewers, editors, staff, CME committee, and other members at the American Association of Clinical Endocrinology who control content have no relevant financial relationships to disclose.

The planners, reviewers, editors, staff, CME committee, and other members at The France Foundation who control content have no relevant financial relationships to disclose.

Faculty Disclosures

Debbie Hinnen, APN, BC-ADM, CDE, FAAN, FAADE, reports that she is a consultant/speaker for Abbott, Boehringer Ingelheim, Lilly, Novo, and Sanofi

Disclosure of Unlabeled Use

AACE and TFF require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. AACE and TFF do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Commercial Support

This activity is supported by educational grants from Abbott Diabetes Care, Amgen, Lilly, Medtronic, Merck-Pfizer Alliance, Novo Nordisk, Radius Health, Inc., Rhythm Pharmaceuticals, and Sandoz Inc., a Novartis Division.

Disclaimer

The American Association of Clinical Endocrinology and The France Foundation present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The American Association of Clinical Endocrinology, The France Foundation, and the commercial supporter(s) assume no liability for the information herein.

Osteoporosis Updates: Primary Care’s Critical Role

Learning Objectives

Upon completion of the activity, participants should be able to:

  • Identify key aspects of the workup for osteoporosis
  • Explain aspects of patient presentation and/or course that necessitate referral to an endocrinologist
  • Summarize key characteristics of evidence-based assessment and treatment options for osteoporosis
  • Formulate a management plan that includes steps/strategies supporting optimal PCP-endocrinologist collaboration

Faculty

Daniel L. Hurley, MD
Consultant; Division of Endocrinology, Diabetes, Metabolism, and Nutrition
Mayo Clinic
Rochester, MN

Accreditation

This activity is provided by American College of Endocrinology in collaboration with The France Foundation.

Target Audience

This educational initiative is intended for primary care physicians, advanced practice professionals (nurse practitioners and physician assistants), nurses, and diabetes educators who care for patients with diseases and disorders of the endocrine system

Statement of Need

In the United States, endocrine-related conditions are on the rise due to the aging population and growing prevalence of type 2 diabetes (T2DM).[i] With three- to six-month wait times for an appointment and an estimated 43,457 patients for every endocrinologist,[ii] the endocrinologist workforce is not sufficient to meet the current demands of patient care. There is also a projected shortfall of endocrine providers, for whom demand will continue to exceed supply through 2025.

Accreditation Statement

The American College of Endocrinology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Physicians

The American College of Endocrinology designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and AACE. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC Medical Knowledge point(s) in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC point(s) equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Disclosures/Conflicts of Interest

Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, The American Association of Clinical Endocrinology (AACE) and The France Foundation (TFF) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. AACE and TFF resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, AACE and TFF seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. AACE and TFF are committed to providing learners with high-quality CME.

Activity Staff Disclosures

The planners, reviewers, editors, staff, CME committee, and other members at the American Association of Clinical Endocrinology who control content have no relevant financial relationships to disclose.

The planners, reviewers, editors, staff, CME committee, and other members at The France Foundation who control content have no relevant financial relationships to disclose.

Faculty Disclosures

The following faculty report that they have no relevant financial relationships to disclose:
Daniel L. Hurley, MD, has no financial relationships to disclose

Disclosure of Unlabeled Use

AACE and TFF require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. AACE and TFF do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Commercial Support

This activity is supported by educational grants from Abbott Diabetes Care, Amgen, Lilly, Medtronic, Merck-Pfizer Alliance, Novo Nordisk, Radius Health, Inc., Rhythm Pharmaceuticals, and Sandoz Inc., a Novartis Division.

Disclaimer

The American Association of Clinical Endocrinology and The France Foundation present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The American Association of Clinical Endocrinology, The France Foundation, and the commercial supporter(s) assume no liability for the information herein.

Primary Care and Dyslipidemia: What Should You Do?

Learning Objectives

Upon completion of the activity, participants should be able to:

  • Identify key aspects of the workup for dyslipidemia
  • Explain aspects of patient presentation and/or course that necessitate referral to an endocrinologist
  • Summarize key characteristics of evidence-based assessment and treatment options for dyslipidemia
  • Formulate a management plan that includes steps/strategies supporting optimal PCP-endocrinologist collaboration

Faculty

Charles Vega, MD
University of California Irvine
Irvine, CA

Accreditation

This activity is provided by American College of Endocrinology in collaboration with The France Foundation.

Target Audience

This educational initiative is intended for primary care physicians, advanced practice professionals (nurse practitioners and physician assistants), nurses, and diabetes educators who care for patients with diseases and disorders of the endocrine system

Statement of Need

In the United States, endocrine-related conditions are on the rise due to the aging population and growing prevalence of type 2 diabetes (T2DM).[i] With three- to six-month wait times for an appointment and an estimated 43,457 patients for every endocrinologist,[ii] the endocrinologist workforce is not sufficient to meet the current demands of patient care. There is also a projected shortfall of endocrine providers, for whom demand will continue to exceed supply through 2025.

Accreditation Statement

The American College of Endocrinology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Physicians

The American College of Endocrinology designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and AACE. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC Medical Knowledge point(s) in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC point(s) equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Disclosures/Conflicts of Interest

Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, The American Association of Clinical Endocrinology (AACE) and The France Foundation (TFF) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. AACE and TFF resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, AACE and TFF seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. AACE and TFF are committed to providing learners with high-quality CME.

Activity Staff Disclosures

The planners, reviewers, editors, staff, CME committee, and other members at the American Association of Clinical Endocrinology who control content have no relevant financial relationships to disclose.

The planners, reviewers, editors, staff, CME committee, and other members at The France Foundation who control content have no relevant financial relationships to disclose.

Faculty Disclosures

Charles Vega, MD, reports that he serves as a consultant for Johnson and Johnson, for which he receives a consultant fee.

Disclosure of Unlabeled Use

AACE and TFF require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. AACE and TFF do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Commercial Support

This activity is supported by educational grants from Abbott Diabetes Care, Amgen, Lilly, Medtronic, Merck-Pfizer Alliance, Novo Nordisk, Radius Health, Inc., Rhythm Pharmaceuticals, and Sandoz Inc., a Novartis Division.

Disclaimer

The American Association of Clinical Endocrinology and The France Foundation present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The American Association of Clinical Endocrinology, The France Foundation, and the commercial supporter(s) assume no liability for the information herein.

Staying Current in Obesity Management: Key Updates for Primary Care

Learning Objectives

Upon completion of the activity, participants should be able to:

  • Identify key aspects of the workup for obesity
  • Explain aspects of patient presentation and/or course that necessitate referral to an endocrinologist
  • Summarize key characteristics of evidence-based assessment and treatment options for obesity
  • Formulate a management plan that includes steps/strategies supporting optimal PCP-endocrinologist collaboration

Faculty

Sangeeta Kashyap, MD
Cleveland Clinic Lerner College of Medicine
Cleveland, OH

Accreditation

This activity is provided by American College of Endocrinology in collaboration with The France Foundation.

Target Audience

This educational initiative is intended for primary care physicians, advanced practice professionals (nurse practitioners and physician assistants), nurses, and diabetes educators who care for patients with diseases and disorders of the endocrine system

Statement of Need

In the United States, endocrine-related conditions are on the rise due to the aging population and growing prevalence of type 2 diabetes (T2DM).[i] With three- to six-month wait times for an appointment and an estimated 43,457 patients for every endocrinologist,[ii] the endocrinologist workforce is not sufficient to meet the current demands of patient care. There is also a projected shortfall of endocrine providers, for whom demand will continue to exceed supply through 2025.

Accreditation Statement

The American College of Endocrinology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Physicians

The American College of Endocrinology designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and AACE. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC Medical Knowledge point(s) in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC point(s) equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Disclosures/Conflicts of Interest

Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, The American Association of Clinical Endocrinology (AACE) and The France Foundation (TFF) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. AACE and TFF resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, AACE and TFF seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. AACE and TFF are committed to providing learners with high-quality CME.

Activity Staff Disclosures

The planners, reviewers, editors, staff, CME committee, and other members at the American Association of Clinical Endocrinology who control content have no relevant financial relationships to disclose.

The planners, reviewers, editors, staff, CME committee, and other members at The France Foundation who control content have no relevant financial relationships to disclose.

Faculty Disclosures

Sangeeta Kashyap, MD, serves as a consultant for Fractyl Health and GI Dynamics, and is the principal investigator for a clinical trial supported by Fractyl Health.

Disclosure of Unlabeled Use

AACE and TFF require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. AACE and TFF do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Commercial Support

This activity is supported by educational grants from Abbott Diabetes Care, Amgen, Lilly, Medtronic, Merck-Pfizer Alliance, Novo Nordisk, Radius Health, Inc., Rhythm Pharmaceuticals, and Sandoz Inc., a Novartis Division.

Disclaimer

The American Association of Clinical Endocrinology and The France Foundation present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The American Association of Clinical Endocrinology, The France Foundation, and the commercial supporter(s) assume no liability for the information herein.

Thyroid Assessment: Updates for Primary Care

Learning Objectives

Upon completion of the activity, participants should be able to:

  • Identify key aspects of the workup for a thyroid disorder
  • Explain aspects of patient presentation and/or course that necessitate referral to an endocrinologist
  • Summarize key characteristics of evidence-based assessment and treatment options for a thyroid disorder
  • Formulate a management plan that includes steps/strategies supporting optimal PCP-endocrinologist collaboration

Faculty

Ji Hyun Chun (CJ), PA-C, MPAS, BC-ADM
Medical Science Liaison, Corcept Therapeutics
OptumCare Medical Group: Endocrinology, Orange County, CA
Immediate Past-President, American Society of Endocrine Physician Assistants (ASEPA)
Editorial Board, Clinician Reviews

Accreditation

This activity is provided by American College of Endocrinology in collaboration with The France Foundation.

Target Audience

This educational initiative is intended for primary care physicians, advanced practice professionals (nurse practitioners and physician assistants), nurses, and diabetes educators who care for patients with diseases and disorders of the endocrine system

Statement of Need

In the United States, endocrine-related conditions are on the rise due to the aging population and growing prevalence of type 2 diabetes (T2DM).[i] With three- to six-month wait times for an appointment and an estimated 43,457 patients for every endocrinologist,[ii] the endocrinologist workforce is not sufficient to meet the current demands of patient care. There is also a projected shortfall of endocrine providers, for whom demand will continue to exceed supply through 2025.

Accreditation Statement

The American College of Endocrinology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Physicians

The American College of Endocrinology designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and AACE. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC Medical Knowledge point(s) in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC point(s) equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Disclosures/Conflicts of Interest

Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, The American Association of Clinical Endocrinology (AACE) and The France Foundation (TFF) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. AACE and TFF resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, AACE and TFF seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. AACE and TFF are committed to providing learners with high-quality CME.

Activity Staff Disclosures

The planners, reviewers, editors, staff, CME committee, and other members at the American Association of Clinical Endocrinology who control content have no relevant financial relationships to disclose.

The planners, reviewers, editors, staff, CME committee, and other members at The France Foundation who control content have no relevant financial relationships to disclose.

Faculty Disclosures

Ji Hyun Chun (CJ), PA-C, MPAS, BC-ADM, reports no financial relationship directly relating to the presenting topic, but does receive a salary from Corcept Therapeutics.

All conflict of interest disclosures have been mitigated by limiting the scope of the educational content and/or conducting content reviews.

Disclosure of Unlabeled Use

AACE and TFF require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. AACE and TFF do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Commercial Support

This activity is supported by educational grants from Abbott Diabetes Care, Amgen, Lilly, Medtronic, Merck-Pfizer Alliance, Novo Nordisk, Radius Health, Inc., Rhythm Pharmaceuticals, and Sandoz Inc., a Novartis Division.

Disclaimer

The American Association of Clinical Endocrinology and The France Foundation present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The American Association of Clinical Endocrinology, The France Foundation, and the commercial supporter(s) assume no liability for the information herein.